Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Salomao V.: Innovation in Hemophilia A Is Also About How Patients Receive Their Treatment
Nov 19, 2026, 22:15

Salomao V.: Innovation in Hemophilia A Is Also About How Patients Receive Their Treatment

Salomao V., Partner in the Biopharmaceutical Industry, shared a post on LinkedIn:

“It’s encouraging to see more treatment options becoming available for people living with rare diseases. Novo Nordisk has received European Commission approval for Frehemgo, a new treatment for people with hemophilia A.

One thing that caught my attention is the flexibility in dosing.

Patients can receive it as a simple injection under the skin, with options ranging from once a week to once a month.

For people who need ongoing preventive treatment, having more flexible options could make everyday life a little easier.

I think developments like this show why innovation in biopharmaceuticals matters.

It’s not just about developing new drugs, but also finding ways to make treatment more manageable for patients.”

Stay updated with Hemostasis Today.